Literature DB >> 22705493

Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.

Peter J Winsauer1, Catalin M Filipeanu, Evangeline M Bailey, Jerielle L Hulst, Jessie L Sutton.   

Abstract

Marijuana abuse during adolescence may alter its abuse liability during adulthood by modifying the interoceptive (discriminative) stimuli produced, especially in females due to an interaction with ovarian hormones. To examine this possibility, either gonadally intact or ovariectomized (OVX) female rats received 40 intraperitoneal injections of saline or 5.6 mg/kg of Δ⁹-THC daily during adolescence, yielding 4 experimental groups (intact/saline, intact/Δ⁹-THC, OVX/saline, and OVX/Δ⁹-THC). These groups were then trained to discriminate Δ⁹-THC (0.32-3.2 mg/kg) from saline under a fixed-ratio (FR) 20 schedule of food presentation. After a training dose was established for the subjects in each group, varying doses of Δ⁹-THC were substituted for the training dose to obtain dose-effect (generalization) curves for drug-lever responding and response rate. The results showed that: 1) the OVX/saline group had a substantially higher mean response rate under control conditions than the other three groups, 2) both OVX groups had higher percentages of THC-lever responding than the intact groups at doses of Δ⁹-THC lower than the training dose, and 3) the OVX/Δ⁹-THC group was significantly less sensitive to the rate-decreasing effects of Δ⁹-THC compared to other groups. Furthermore, at sacrifice, western blot analyses indicated that chronic Δ⁹-THC in OVX and intact females decreased cannabinoid type-1 receptor (CB1R) levels in the striatum, and decreased phosphorylation of cyclic adenosine monophosphate response element binding protein (p-CREB) in the hippocampus. In contrast to the hippocampus, chronic Δ⁹-THC selectively increased p-CREB in the OVX/saline group in the striatum. Extracellular signal-regulated kinase (ERK) was not significantly affected by either hormone status or chronic Δ⁹-THC. In summary, these data in female rats suggest that cannabinoid abuse by adolescent human females could alter their subsequent responsiveness to cannabinoids as adults and have serious consequences for brain development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705493      PMCID: PMC3402337          DOI: 10.1016/j.pbb.2012.06.008

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  44 in total

1.  Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.

Authors:  Tanya L Daigle; Christopher S Kearn; Ken Mackie
Journal:  Neuropharmacology       Date:  2007-06-26       Impact factor: 5.250

2.  Theoretical and methodological considerations on drug discrimination learning.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacologia       Date:  1976-03-16

3.  Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.

Authors:  S González; T Bisogno; T Wenger; J Manzanares; A Milone; F Berrendero; V Di Marzo; J A Ramos; J J Fernández-Ruiz
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

4.  Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status.

Authors:  Peter J Winsauer; Jill M Daniel; Catalin M Filipeanu; Stuart T Leonard; Jerielle L Hulst; Shaefali P Rodgers; Caroline L Lassen-Greene; Jessie L Sutton
Journal:  Addict Biol       Date:  2011-01       Impact factor: 4.280

5.  Dose and time effects of estrogen on expression of neuron-specific protein and cyclic AMP response element-binding protein and brain region volume in the medial amygdala of ovariectomized rats.

Authors:  Lu Fan; Rose Hanbury; Subhash C Pandey; Rochelle S Cohen
Journal:  Neuroendocrinology       Date:  2008-04-29       Impact factor: 4.914

6.  Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement.

Authors:  F Rodríguez de Fonseca; M Cebeira; J A Ramos; M Martín; J J Fernández-Ruiz
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

7.  Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats.

Authors:  A H Lichtman; K R Dimen; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

8.  Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.

Authors:  R S Mansbach; C C Rovetti; E N Winston; J A Lowe
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

9.  Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.

Authors:  J L Wiley; J A Lowe; R L Balster; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1995-10       Impact factor: 4.030

10.  Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.

Authors:  Tiziana Rubino; Daniela Viganò; Fabrizio Premoli; Chiara Castiglioni; Silvia Bianchessi; Renata Zippel; Daniela Parolaro
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.682

View more
  10 in total

1.  Effects of cocaine on the discriminative stimulus and reinforcing effects of mephedrone in male rats.

Authors:  Laura L Erwin; Mark R Nilges; Zachary B Bondy; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

2.  Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.

Authors:  Jenny L Wiley; Timothy W Lefever; Julie A Marusich; Rebecca M Craft
Journal:  Drug Alcohol Depend       Date:  2017-01-11       Impact factor: 4.492

Review 3.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.

Authors:  Ziva D Cooper; Rebecca M Craft
Journal:  Neuropsychopharmacology       Date:  2017-07-17       Impact factor: 7.853

4.  Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats.

Authors:  Kurt J Varner; Kyle Daigle; Peter F Weed; Peter B Lewis; Sarah E Mahne; Ananthakrishnan Sankaranarayanan; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2012-09-13       Impact factor: 4.530

5.  Do you feel it now? Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice.

Authors:  Jenny L Wiley; Timothy W Lefever; Michelle Glass; Brian F Thomas
Journal:  Neurotoxicology       Date:  2019-04-03       Impact factor: 4.294

6.  Mechanisms Underlying Sex Differences in Cannabis Use.

Authors:  Katina C Calakos; Shivani Bhatt; Dawn W Foster; Kelly P Cosgrove
Journal:  Curr Addict Rep       Date:  2017-10-19

Review 7.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

8.  Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats.

Authors:  Peter J Winsauer; Catalin M Filipeanu; Peter F Weed; Jessie L Sutton
Journal:  Front Pharmacol       Date:  2015-07-02       Impact factor: 5.810

9.  Sex, species and age: Effects of rodent demographics on the pharmacology of ∆9-tetrahydrocanabinol.

Authors:  Jenny L Wiley; Daniel G Barrus; Charlotte E Farquhar; Timothy W Lefever; Thomas F Gamage
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-08-15       Impact factor: 5.067

10.  Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats.

Authors:  Jenny L Wiley; Shanequa I Taylor; Julie A Marusich
Journal:  Drug Alcohol Depend       Date:  2021-06-23       Impact factor: 4.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.